Clinical trials
Adenocarcinoma trials in the United States with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
17 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2006 | 1 |
| 2008 | 2 |
| 2010 | 1 |
| 2011 | 1 |
| 2013 | 2 |
| 2014 | 2 |
| 2015 | 1 |
| 2020 | 1 |
| 2023 | 1 |
| 2025 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 10 |
| Recruiting | 3 |
| Enrolling by invitation | 2 |
| Not yet recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Mauna Kea Technologies | 2 |
| University of Rochester | 2 |
| Brigham and Women's Hospital | 1 |
| Delfi Diagnostics Inc. | 1 |
| Fox Chase Cancer Center | 1 |
| H. Lee Moffitt Cancer Center and Research Institute | 1 |
| Mayo Clinic | 1 |
| National Institutes of Health Clinical Center (CC) | 1 |
| Ohio State University Comprehensive Cancer Center | 1 |
| Queensland Centre for Gynaecological Cancer | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Adenocarcinoma | 17 |
| Prostatic Neoplasms | 7 |
| Neoplasms | 3 |
| Barrett Esophagus | 2 |
| Disease | 2 |
| Lung Neoplasms | 2 |
| Pancreatic Neoplasms | 2 |
| Adenocarcinoma in Situ | 1 |
| Adenocarcinoma, Bronchiolo-Alveolar | 1 |
| Breast Neoplasms | 1 |
Trials
Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.